Insurtech funding reaches record high

A cash injection syringe

The numbers from Willis Towers Watson, showed there were seven $30m investment rounds completed during the quarter.

Moreover, the line between funding from incumbent (re)insurers and venture capital

To continue reading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: